Verastem | VSTM - Cost Of Sales


Verastem reported $0 in Cost of Sales for its fiscal quarter ending in December of 2021.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
AstraZeneca USD 3.27B 471M Dec/2025
Curis USD 10.27M 610K Jun/2024
Cytokinetics USD 99.23M 13.32M Sep/2025
Gilead Sciences USD 1.62B 50M Dec/2025
Incyte USD 121.18M 22.18M Dec/2025
Laboratory Of America USD 2.6B 56.8M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
TG Therapeutics USD 38.14M 10.05M Dec/2025
Verastem USD 0 0 Dec/2021